Showing results (171-180 of 184) with videos related to
Sort By:
Pageof 19
Bioorganic & Medicinal Chemistry Letters|August 30, 2008
Hexahydro-pyrrolo- and hexahydro-1H-pyrido[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Zhongxiang Sun, Benjamin K Ayida, et al.Leukemia|May 24, 2016
Small molecule inhibition of cAMP response element binding protein in human acute myeloid leukemia cellsB Mitton, H-D Chae, K Hsu, et al.Contemporary Clinical Trials|May 14, 2025
Assessing the effect of virtual navigation interventions to improve health insurance literacy and decrease financial burden in cancer survivors: The HINT II study protocolElyse R Park, Anne C Kirchhoff, Calli O Mitchell, et al.Frontiers in Pediatrics|November 17, 2022
Energy cost of walking in obese survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime CohortMatthew D Wogksch, Emily R Finch, Vikki G Nolan, et al.Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK propertiesMaria V Sergeeva, Yuefen Zhou, Darian M Bartkowski, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2008
Pyrrolo[1,2-b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymeraseFrank Ruebsam, Stephen E Webber, Martin T Tran, et al.Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymeraseSun Hee Kim, Martin T Tran, Frank Ruebsam, et al.Bioorganic & Medicinal Chemistry Letters|May 7, 2008
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessmentsLian-Sheng Li, Yuefen Zhou, Douglas E Murphy, et al.Bioorganic & Medicinal Chemistry Letters|October 3, 2009
5,5'- and 6,6'-dialkyl-5,6-dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Chinh V Tran, et al.Bioorganic & Medicinal Chemistry Letters|July 30, 2008
4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymeraseDavid A Ellis, Julie K Blazel, Stephen E Webber, et al.Pageof 19